Bradley Merrill Thompson Quoted in “FDA Says It Won’t Regulate Fitbit, Many Other Fitness Wearables”

The Advisory Board’s The Daily Briefing

Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office was quoted in The Advisory Board’s The Daily Briefing special report titled “FDA Says It Won't Regulate Fitbit, Many Other Fitness Wearables.”

Following is an excerpt:

Bradley Merrill Thompson—an attorney with Epstein, Becker & Green—said the guidance "strikes the right balance between regulation and innovation."